TTRX — Turn Therapeutics Share News
0.000.00%
Last trade - 00:00- $310.82m
- $306.60m
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Turn Therapeutics Reports Interim Analysis Findings And Adaptive Optimization Strategy From Phase 2 GX-03 Trial In Moderate-To-Severe Atopic Dermatitis
Brief: Turn Therapeutics Reports First Quarter 2026 Financial Results
Brief: Turn Therapeutics Announces Corporate And Pipeline Updates And 2026 Outlook Ahead Of The 44Th Annual J.P. Morgan Healthcare Conference
Brief: Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
Brief: Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
Brief: Turn Therapeutics files prospectus relates to offer, sale of up to 7 mln shares